Kuiying Xu

1.5k total citations
47 papers, 1.2k citations indexed

About

Kuiying Xu is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Kuiying Xu has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Infectious Diseases. Recurrent topics in Kuiying Xu's work include Receptor Mechanisms and Signaling (9 papers), PARP inhibition in cancer therapy (9 papers) and DNA and Nucleic Acid Chemistry (8 papers). Kuiying Xu is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), PARP inhibition in cancer therapy (9 papers) and DNA and Nucleic Acid Chemistry (8 papers). Kuiying Xu collaborates with scholars based in United States, Germany and Sweden. Kuiying Xu's co-authors include Robert H. Mach, Mehran Makvandi, Frank Seela, Chenbo Zeng, Harrison D. Winters, Chia‐Ju Hsieh, Sean W. Reilly, Chi-Chang Weng, Daniel A. Pryma and Catherine Hou and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Scientific Reports.

In The Last Decade

Kuiying Xu

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuiying Xu United States 19 615 310 159 152 137 47 1.2k
Marilena Manea Germany 21 746 1.2× 281 0.9× 103 0.6× 118 0.8× 176 1.3× 50 1.4k
Ritwik Burai United States 14 602 1.0× 143 0.5× 690 4.3× 40 0.3× 113 0.8× 19 1.4k
R. Scott Struthers United States 25 933 1.5× 235 0.8× 368 2.3× 82 0.5× 368 2.7× 78 2.0k
Hongzhi Li China 24 1.0k 1.7× 388 1.3× 100 0.6× 42 0.3× 46 0.3× 70 1.5k
Patrick Schindler Switzerland 20 1.0k 1.7× 173 0.6× 102 0.6× 124 0.8× 77 0.6× 51 1.6k
Roland Neuhaus Germany 16 732 1.2× 191 0.6× 65 0.4× 32 0.2× 123 0.9× 35 1.1k
Michael A. Stashko United States 23 708 1.2× 160 0.5× 116 0.7× 26 0.2× 340 2.5× 51 1.5k
Indira Sen United States 19 786 1.3× 110 0.4× 111 0.7× 40 0.3× 63 0.5× 42 1.2k
Silvia Mari Italy 19 848 1.4× 86 0.3× 320 2.0× 116 0.8× 217 1.6× 28 1.4k
Xiaoshan Min United States 22 1.3k 2.1× 199 0.6× 56 0.4× 55 0.4× 206 1.5× 34 2.0k

Countries citing papers authored by Kuiying Xu

Since Specialization
Citations

This map shows the geographic impact of Kuiying Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuiying Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuiying Xu more than expected).

Fields of papers citing papers by Kuiying Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuiying Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuiying Xu. The network helps show where Kuiying Xu may publish in the future.

Co-authorship network of co-authors of Kuiying Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kuiying Xu. A scholar is included among the top collaborators of Kuiying Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuiying Xu. Kuiying Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Kuiying, et al.. (2025). A nanoluciferase complementation-based assay for monitoring β-arrestin2 recruitment to the dopamine D3 receptor. Biochemistry and Biophysics Reports. 42. 102019–102019. 1 indexed citations
2.
Weng, Chi-Chang, Aladdin Riad, Brian P. Lieberman, et al.. (2022). Characterization of Sigma-2 Receptor—Specific Binding Sites Using [3H]DTG and [125I]RHM-4. Pharmaceuticals. 15(12). 1564–1564. 6 indexed citations
3.
Hsieh, Chia‐Ju, Catherine Hou, Yi Zhu, et al.. (2022). [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice. EJNMMI Research. 12(1). 43–43. 8 indexed citations
4.
Hsieh, Chia‐Ju, Aladdin Riad, Ji Youn Lee, et al.. (2021). Interaction of Ligands for PET with the Dopamine D3 Receptor: In Silico and In Vitro Methods. Biomolecules. 11(4). 529–529. 6 indexed citations
5.
Riad, Aladdin, Sarah B. Gitto, Hwan Lee, et al.. (2020). PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response. Molecules. 25(24). 6029–6029. 21 indexed citations
6.
Makvandi, Mehran, Hwan Lee, Laura N. Puentes, et al.. (2019). Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models. Molecular Cancer Therapeutics. 18(7). 1195–1204. 39 indexed citations
7.
Reilly, Sean W., Aladdin Riad, Chia‐Ju Hsieh, et al.. (2019). Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). Journal of Medicinal Chemistry. 62(10). 5132–5147. 15 indexed citations
8.
Weng, Chi-Chang, Sean Carlin, Catherine Hou, et al.. (2019). Correlation analysis of [18F]ROStrace using ex vivo autoradiography and dihydroethidium fluorescent imaging in lipopolysaccharide-treated animals. Biochemical and Biophysical Research Communications. 516(2). 397–401. 7 indexed citations
9.
Hsieh, Chia‐Ju, Kuiying Xu, Thomas J. A. Graham, et al.. (2018). Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in Vitro. ACS Omega. 3(4). 4486–4493. 34 indexed citations
10.
Hsieh, Chia‐Ju, John J. Ferrie, Kuiying Xu, et al.. (2018). Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules. ACS Chemical Neuroscience. 9(11). 2521–2527. 59 indexed citations
11.
Doot, Robert K., Jacob G. Dubroff, Joshua Scheuermann, et al.. (2018). Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride. EJNMMI Physics. 5(1). 21–21. 6 indexed citations
12.
Riad, Aladdin, Chenbo Zeng, Chi-Chang Weng, et al.. (2018). Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex. Scientific Reports. 8(1). 16845–16845. 97 indexed citations
13.
Reilly, Sean W., Mehran Makvandi, Kuiying Xu, & Robert H. Mach. (2018). Rapid Cu-Catalyzed [211At]Astatination and [125I]Iodination of Boronic Esters at Room Temperature. Organic Letters. 20(7). 1752–1755. 72 indexed citations
14.
Makvandi, Mehran, Lilie L. Lin, Kuiying Xu, et al.. (2017). PARP-1 Expression Quantified by [ 18 F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy. Cancer Biotherapy and Radiopharmaceuticals. 32(1). 9–15. 22 indexed citations
15.
Makvandi, Mehran, Kuiying Xu, Brian P. Lieberman, et al.. (2016). A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy. Cancer Research. 76(15). 4516–4524. 80 indexed citations
16.
Makvandi, Mehran, Kuiying Xu, Brian P. Lieberman, et al.. (2016). Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivo. Nuclear Medicine and Biology. 43(12). 752–758. 30 indexed citations
17.
Makvandi, Mehran, Brian P. Lieberman, Chenbo Zeng, et al.. (2015). The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer. Biochemical and Biophysical Research Communications. 467(4). 1070–1075. 18 indexed citations
18.
Marchais‐Oberwinkler, Sandrine, Claudia Henn, Gabriele Möller, et al.. (2010). 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development. The Journal of Steroid Biochemistry and Molecular Biology. 125(1-2). 66–82. 170 indexed citations
19.
20.
Seela, Frank, Xiaohua Peng, & Kuiying Xu. (2007). Mismatch Discrimination of Base-Modified Nucleic Acids and their Constituents: Non-Watson-Crick Base Pairing Induced by Tautomerization. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1569–1572. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilena Manea Breakdown of academic impact, for papers by Ritwik Burai Breakdown of academic impact, for papers by R. Scott Struthers Breakdown of academic impact, for papers by Hongzhi Li Breakdown of academic impact, for papers by Patrick Schindler Breakdown of academic impact, for papers by Roland Neuhaus Breakdown of academic impact, for papers by Michael A. Stashko Breakdown of academic impact, for papers by Indira Sen Breakdown of academic impact, for papers by Silvia Mari Breakdown of academic impact, for papers by Xiaoshan Min
Rankless by CCL
2026